We invest in the future
– with people and growth in focus
About
With more than a century of industrial entrepreneurship, Bagger-Sørensen Equity A/S invests long-term family capital in established small and medium-sized companies with clear potential to scale.
Empowering Ambition Through Active Ownership
We invest in companies where active ownership and capital unlock ambitious agendas and help them realise their full potential. Our role is to strengthen businesses in a responsible way, always balancing the interests of society, customers, employees, partners and shareholders.
We are open to dialogue on investment opportunities. Contact us to start the conversation.
Our history
1915
Vejle Caramel og Tablet fabrik (Vejle caramel and tablet factory) was established
1927
Chewing gum production in Strandgade, Vejle, Denmark
1939
The DANDY name was launched
1946
Exports started up
1952
New factory at Enghavevej
1956
The first functionel gum (Stimorol) was launched
1972
New factory at Dandyvej
1975
Holger Bagger-Sørensen was appointed CEO
1978
Acquisition of Fertin AB, Sweden
1982
A factory was established in Zimbabwe
1984
DANDY Fonden (Foundation) was established
1987
Production of private brand to Kraft Foods France (e.g. Hollywood)
1991
Holger Bagger-Sørensen retired as CEO and became Chairman of the Board in DANDY A/S
1999
Inauguration of the Dirol factory in Russia
2002
Cadbury bought the DANDY brands, the international sales organization and the factory in Russia. The company name was changed to Gumlink A/S.
2004
Inauguration of Fertin P2 (FDA approved plant)
2009
Joint venture with Yildiz Holding, Turkey
2013
Steen and Claus Bagger-Sørensen became Chairmen of the Boards in Fertin Pharma, Gumlink, Vecata and BS
2015
The first 100 years were celebrated in Vejle with 1200 guests. Inauguration of the Fertin plant in Goa, India
2016
Steen and Claus Bagger-Sørensen succeeded Holger Bagger-Sørensen on all board positions
2017
Fertin Pharma A/S was sold to EQT (BS&Co. kept 30% of the shares)
2020
The Bagger-Sørensen group moved to the BS HQ at Tabletvej in Vejle
2021
EQT and the Bagger-Sørensen Family sold Fertin Pharma to Philip Morris
Investing with Purpose, Building for the Long Term
With more than 100 years of industrial entrepreneurship, Bagger-Sørensen Equity builds on a legacy of creating and growing well-run companies. That spirit still guides us.
Our journey has evolved into partnering with established small and medium-sized businesses that have the potential to scale. With long-term family capital and active ownership, we help companies unlock their potential, turning ambition into lasting and durable results.
Our experience shape how we think and what we do
A symbol of our continuous journey of value creation—an active loop where motivation, margin, and capital reinforce one another to drive long-term success. At the core is a dedicated team translating ambition into performance through growth, efficiency, and disciplined operations.
Each turning point anchors a foundation of our approach:
People, Innovation, Growth, and Operations.
References
Some of the businesses we have engaged in on their journey — creating long-term value through close collaboration, strategic insight, and active ownership
DANDY A/S
Industry: Confectionery
Ownership period: 1915-2002
Shareholding: 100%
Facts
Turnover: 2.5 Bio. DKK
2.500 Employees
Creation of iconic Chewing Gum brands like Stimorol®, Dirol® and V6®
Strategic development
Brands, factory in Russia and all sales subsidiaries divested to Cadbury Schweppes in 2002 in order for the branded business to take part in a global consolidation within chewing gum and confectionery.
Bagger-Sørensen family retained ownership of all B2B related activities continuing in Gumlink A/S.
Gumlink A/S
Industry: Confectionery
Ownership period: 2002 ->
Shareholding: 100%
Facts
B2B Chewing gum –> obtaining +60% SOM in European Private Label from 2002 -> 2008
Strong Operational Model developed and implemented allowing industry leading productivity performance and Customer Service.
Strategic development
Transformation in 2009 based on decision to globalize and improve competitiveness through formation of several Joint Ventures (India, Zimbabwe/South Africa, Mexico, Canada and Turkey).
Manufacturing in Denmark seized in 2012 and Gumlink A/S became a holding company for Joint Venture investments within confectionery.
Fertin Pharma A/S
Industry: Pharmaceuticals
Ownership period: 1978-2021
Shareholding: 70% of shareholding divested to EQT in 2017
Facts
Turnover: 1.0 bn. DKK
800 Employees
Industry leading quality standards and global foot print
Strong innovation capabilities and Intellectual Property portfolio
Strategic development
Initially, established Fertin Pharma A/S as the largest CDMO within pharmaceutical chewing gum and smoking cessation gum. Further, developed the company into a world leading CDMO within convenient and pleasurable oral and intra-oral delivery systems across Pharma and Nutraceuticals working with multiple top tier global Pharma and Consumer Health companies.
Continental Confectionery Company Gida San
Industry: Confectionery
Ownership period: 2010 ->
Shareholding: 50%
Facts
Turnover: ~500 mio DKK
900 Employees
Double digit growth year on year
Global B2B sales and own Brands in Turkey/Middle East
Strategic development
Strong combination of own brands in Middle East/Turkey and B2B business model in rest of the world fueled by large scale modern manufacturing in a cost competitive environment coupled with strong innovation and R&D capabilities.
TabLabs Inc.
Industry: Nutraceuticals and Food
Ownership period: 2011-2018
Shareholding: 50%
Facts
Turnover increased from 2.5 Mio. CAN to 15 Mio. CAN
Significant increase in EBITDA
Facility in Langley, Vancouver, Canada upgraded, expanded and BRC (A) and Canada Health certified
Strategic development
Business was diversified into Nutraceuticals. Improved Product Development, Sales and Operations enabling attraction of large MLM customers in US, Canada and China.
Additional references
Okono A/S – 100% ownership – however the Nordik brand was divested in 2018
Medcan Pharma A/S – 100% ownership – divested in 2019
Richmark GmbH – 50/50 JV – exited in 2015
DANDY Zimbabwe, Ltd. – 49% ownership – exited in 2015
Beechies, Ltd., South Africa – 49% ownership – exited in 2015
Lohnpack GmbH – 100% ownership – divested in 2010
Gumpole, Ltd., India – 50/50 JV – exited in 2010
Stargum, Mexico – 50/50 JV – exited in 2013
Arcedi Biotech ApS – 90%
BS Renewable Energy Projects (Scotland) – 100%